Ujvira 160mg Injection

Product Introduction

UJVIRA 160mg Injection contains Trastuzumab (160mg), a monoclonal antibody used in the treatment of HER2-positive breast cancer and gastric cancer. It is a targeted therapy designed to block the HER2 protein, which is responsible for the growth and spread of cancer cells. This medication works by inhibiting the proliferation of cancerous cells and enhancing the body’s immune response against tumors. UJVIRA is administered under the supervision of a healthcare professional and is usually given through an intravenous infusion.

Uses of UJVIRA 160mg Injection

• Treatment of HER2-positive breast cancer (early-stage and metastatic breast cancer)
• Treatment of HER2-positive gastric cancer (metastatic gastroesophageal junction and stomach cancer)
• Used in combination with chemotherapy or as monotherapy based on the patient’s condition and doctor’s recommendation

Benefits of UJVIRA 160mg Injection

1. Effective in HER2-positive Cancer Treatment: UJVIRA specifically targets the HER2 protein, which is overexpressed in some cancers, slowing the progression of the disease and improving survival rates.
2. Enhances Chemotherapy Effectiveness: When used in combination with chemotherapy, it increases the efficacy of cancer treatment and reduces the risk of recurrence.
3. Promotes Better Quality of Life: By reducing tumor size and controlling cancer progression, it helps patients maintain a better quality of life.
4. Well-Studied & Clinically Approved: Trastuzumab has been widely studied and is one of the most effective drugs for HER2-positive breast and gastric cancers.

Side Effects of UJVIRA 160mg Injection

Like all medications, UJVIRA 160mg Injection may cause some side effects. It is important to monitor for any unusual symptoms and consult a doctor if they occur.

Common Side Effects:

• Nausea and vomiting
• Diarrhea or constipation
• Fatigue and weakness
• Headache
• Loss of appetite
• Muscle or joint pain

Serious Side Effects (Require Immediate Medical Attention):

• Heart-related issues such as irregular heartbeat or shortness of breath
• Allergic reactions like rash, swelling, or difficulty breathing
• Infusion-related reactions including fever, chills, or low blood pressure
• Decreased white blood cell count leading to increased infection risk

Frequently Asked Questions (FAQ)

Q1: How is UJVIRA 160mg Injection administered?
A: UJVIRA is given as an intravenous (IV) infusion in a hospital or clinical setting under the supervision of a doctor.

Q2: How long does the treatment with UJVIRA last?
A: The duration of treatment varies depending on the patient’s condition. It can range from several months to a year as per the doctor’s prescription.

Q3: Can I take UJVIRA Injection during pregnancy?
A: No, UJVIRA is not recommended during pregnancy as it may harm the developing fetus. Women of childbearing age should use effective contraception during treatment and for at least 7 months after the last dose.

Q4: Does UJVIRA Injection cause hair loss?
A: Hair loss is not a direct side effect of UJVIRA, but when combined with chemotherapy, it may lead to hair thinning or loss.

Q5: Can I breastfeed while receiving UJVIRA treatment?
A: No, it is advised not to breastfeed while on UJVIRA and for at least 7 months after stopping treatment to prevent potential risks to the infant.

References